Moreover, subgroup analysis showed that cancer risks in GSTM1-null was organ-specific, especially for lung cancer and nasopharyngeal cancer among smokers, and liver cancer, head and neck cancer and stomach cancer among drinkers. The gene discussed is GSTM1; the disease is nasopharyngeal carcinoma.